Evidence map›Paper›PMID 40616127›Full record

ArticleBMC nutrition2025

Stakeholders influence to reduce vitamin A deficiency in children aged 15 to 23 months in Iran: an analysis of stakeholders and networking.

Golnaz Rajaeieh, Ahad Bakhtiari, Masoomeh Gholami, Fatemeh Mohammadi-Nasrabadi, Amirhossein Takian

Abstract read
In one paragraph

Article in BMC nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Golnaz RajaeiehDepartment of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ahad BakhtiariHealth Equity Research Centre (HERC), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Masoomeh GholamiCenter of Excellence for Global Health (CEGH), Department of Global Health and Public Policy, School of Public Health, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Fatemeh Mohammadi-NasrabadiFood and Nutrition Policy and Planning Research Department, National Nutrition and Food Technology Research Institute (NNFTRI), Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
Amirhossein TakianHealth Equity Research Centre (HERC), Tehran University of Medical Sciences (TUMS), Tehran, Iran. takian@tums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimeVitamin A deficiency remains a significant public health concern in developing countries, substantially contributing to morbidity and mortality among young children. In Iran, the prevalence of vitamin A deficiency among children aged 15 to 23 months increased during the decade from 2002 to 2012, mostly due to socio-economic reasons. Given the complexity of managing this deficiency, multiple stakeholders are involved in its prevention and treatment. The objective of this study is to identify these stakeholders and assess their interests, influence, and interconnections to enhance coordinated efforts in addressing vitamin A deficiency.

methodIn this qualitative study, we identified primary and secondary stakeholders through interviews with experts and key informants, as well as content analysis of relevant documents. To examine the interactions between stakeholders' power, interests, and positions, we utilized Policy-Maker software (Version 4). Additionally, we employed Gephi software (Version 0.9.2) for social network analysis, mapping stakeholder relationships to enhance our understanding of their interconnected dynamics.

resultsOur research identified 45 stakeholders, categorized as follows: 71% from the public sector, 4.5% international entities, 11.11% private organizations, and 13% from civil society groups. Additionally, 62% of stakeholders were associated with the executive domain, while 38% belonged to the education sector. Degree centrality ranged from 1 to 12, Closeness centrality scores ranged from 0.25 to 0.67, indicating moderate to high accessibility within the network. Athough the Ministry of Health and Medical Education was identified as the most influential stakeholder, and also it plays a key role in collaboration with other stakeholders, multiple stakeholders, including NGOs, universities, and international organizations such as UNICEF and FAO, also played significant roles in reducing Vitamin A deficiency. Network analysis metrics-including degree, closeness, betweenness, and eigenvector centralities-indicated that the highest degree value was attributed to the Secretariat of the Supreme Council for Health and Food Security (affiliated with the Ministry of Health and Medical Education), UNICEF, FAO, and the Deputy of Public Health within universities of medical sciences.

conclusionAddressing vitamin A deficiency among children aged 15-24 months in Iran requires a coordinated and strategic approach, with the Ministry of Health and Medical Education serving as the key stakeholder. While the ministry plays a central role in legislative efforts and collaboration, the relatively low to medium level of interest among other key stakeholders highlights the need for proactive engagement. Strengthening awareness through targeted advocacy, continuous negotiations, and deliberate outreach can enhance stakeholder involvement and ensure effective policy implementation. By fostering stronger partnerships and promoting informed decision-making, a more sustainable and impactful approach to reducing vitamin A deficiency can be achieved.

Indexed as

ChildrenSocial network analysisStakeholders analysisVitamin A deficiency

Identifiers

PMID40616127
PMCPMC12232006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.